Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWBTT3033 is an inhibitor of integrin α2β1 (EC50 = 130 nM in CHO cells expressing the human receptor).1 It is 8-fold selective for integrin α2β1 over integrin α1β1, as well as laminin 332, 40 kDa fibronectin, 120 kDa fibronectin, and vitronectin at 130 nM. BTT3033 inhibits the adhesion of platelets in isolated mouse whole blood to collagen I-coated capillaries at a constant shear rate (EC50 = 6 µM). In vivo, BTT3033 (10 mg/kg, p.o.) decreases lavage fluid leukocyte infiltration in a mouse model of platelet-activating factor-induced air pouch inflammation.2 It decreases ear thickness in a mouse model of ovalbumin- and alum-induced mouse model of skin hypersensitivity when administered at a dose of 10 mg/kg.
WARNING This product is not for human or veterinary use.
1. Novel α2β1 integrin inhibitors reveal that integrin binding to collagen under shear stress conditions does not require receptor preactivation. The Journal of Biological Chemisty 287(53), 44694-44702 (2012).
2. Sulfonamide inhibitors of α2β1 integrin reveal the essential role of collagen receptors in in vivo models of inflammation. Pharmacol. Res. Perspect. 3(3), e00146 (2015).